University of Leicester
Browse

Mendelian randomization study highlights the role of hematological traits on Type-2 diabetes mellitus in African ancestry individuals

Download (1.45 MB)
journal contribution
posted on 2025-06-30, 11:13 authored by Chisom Soremekun, Daudi Jjingo, David Kateete, Oyekanmi Nash, Dorothea Nitsch, Moffat Nyirenda, Dipender Gill, Eleftheria Zeggini, Harald Grallert, Annette Peters, Tinashe Chikowore, Chiara BatiniChiara Batini, Opeyemi Soremekun, Segun Fatumo
IntroductionObservational studies have identified associations between hematological traits and type-2 diabetes mellitus (T2D). However, it is difficult to infer causal effects due to the potential of confounding. Our study utilizes the Mendelian randomization (MR) approach to address the above limitation and investigate the causal effect of hematological traits such as white blood cell (WBC), platelets (PLT), and red blood cell (RBC) on T2D in individuals of African ancestry.MethodsThe participating cohorts included participants of African ancestry in the Blood Cell consortium and the Million Veteran Program dataset. Using GWAS summary statistics, we applied a univariable and multivariable Two-sample MR to estimate the causal relationship between hematological traits and T2D.ResultsIn the main IVW MR estimates, genetically predicted levels of mean corpuscular hemoglobin concentration (MCHC), mean corpuscular hemoglobin (MCH), and mean corpuscular volume (MCV) were associated with decreased risk of T2D. We also observed a decreased risk of T2D with genetically predicted total WBC count and neutrophil count (NEU), for the WBC traits. The multivariable analysis further supported the direct associations of genetically predicted MCH, MCHC, and MCV levels with a decreased risk of T2D. For the European ancestry, a similar pattern of association was observed for MCH and MCV.DiscussionThese findings indicate that hematological traits may differentially play a role in the development of T2D and be affected by T2D. However, further research is needed to validate and explore the biological pathways and mechanisms involved in these associations.

Funding

Office Of The Director, National Institutes Of Health (OD), National Heart Lung and Blood Institute under award number 5U01HL172180-02

Africa Research Excellence Fund (AREF-325-SORE-F-C0904)

Assessing the impact of genetic variation on chronic kidney disease in Africa

Wellcome Trust

Find out more...

NIH NHGRI award number U01HG013442

Commonwealth Scholarship Commission and the Foreign, Commonwealth and Development Office in the UK and the German Academic Exchange Service (DAAD

History

Author affiliation

College of Life Sciences Population Health Sciences

Version

  • VoR (Version of Record)

Published in

Frontiers in Pharmacology

Volume

16

Pagination

1436972

Publisher

Frontiers Media SA

issn

1663-9812

eissn

1663-9812

Copyright date

2025

Available date

2025-06-30

Spatial coverage

Switzerland

Language

eng

Deposited by

Dr Chiara Batini

Deposit date

2025-05-30

Data Access Statement

Publicly available datasets were analyzed in this study. This data can be found here: http://www.mhi-humangenetics.org/en/resources/.

Usage metrics

    University of Leicester Publications

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC